HomeANVS • NYSE
add
Annovis Bio Inc
Previous close
$1.30
Day range
$1.23 - $1.35
Year range
$1.11 - $20.00
Market cap
24.16M USD
Avg Volume
262.29K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
Market news
MarketWatch
14 hours ago
S&P 500 tallies its first ‘death cross’ in 3 years. Here’s what happens next.
0.79%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.73M | -35.50% |
Net income | -5.86M | 73.60% |
Net profit margin | — | — |
Earnings per share | -0.43 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.55M | 83.36% |
Total assets | 13.93M | 36.42% |
Total liabilities | 4.62M | -74.29% |
Total equity | 9.31M | — |
Shares outstanding | 19.49M | — |
Price to book | 1.97 | — |
Return on assets | -119.04% | — |
Return on capital | -205.69% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -5.86M | 73.60% |
Cash from operations | -8.29M | 11.53% |
Cash from investing | — | — |
Cash from financing | 6.20M | -29.25% |
Net change in cash | -2.08M | -247.32% |
Free cash flow | -5.89M | -6.72% |
About
Founded
2008
Headquarters
Website
Employees
8
